Anticholinergic Use Is a Major Risk Factor for Dysphonia

作者：Haft Sunny^*; Farquhar Douglas; Carey Ryan; Mirza Natasha

来源：Annals of Otology, Rhinology and Laryngology, 2015, 124(10): 797-802.

DOI：10.1177/0003489415585867

• anticholinergic
• dysphonia
• GRBAS
• hoarseness
• laryngitis
• medications
• RSI
• sicca
• VHI
• voice

Objective: We hypothesize that many cases of dysphonia of unclear etiology are a form of sicca caused by anticholinergic medication use, and we aim to determine their association.
Study Design: This was a cross-sectional study conducted over a 6-month time period. Participants were drawn from a tertiary care laryngology practice within an academic institution.
Methods: One hundred forty-nine patients met inclusion criteria. Patients rated the symptom of chronic hoarseness; scores were compared with participants' medication lists, comorbidities, age, and sex, and a multivariate logistic regression model was developed. Significance was set at P < .05. As a secondary analysis, participants rated a variety of other symptoms using the Voice Handicap Index-10, Reflux Symptom Index, and the GRBAS scale, which were likewise compared to anticholinergic use.
Results: Any patient taking at least 1 anticholinergic medication had a 2.32 increased odds (P = .03) of experiencing hoarseness. If the patient was taking 2 or more anticholinergic medications, those odds rose to 4.52 (P = .009).
Conclusion: This is the first study, to our knowledge, that implicates medication use as a major risk factor for dysphonia of unclear etiology. An awareness of this association is invaluable when attributing cause to hoarseness and when considering treatment options.

• 出版日期2015-10